Our News on Newswise

Mortality rate after cancer surgery drops during 10-year period, but gap persists between Black and white patients

Mortality rates after cancer surgery declined for Black as well as white patients during a recent ten-year period, although the mortality gap between the two groups did not narrow, according to new research by Dana-Farber Cancer Institute, Brigham...
2-Dec-2020 11:05 AM EST Add to Favorites

Dana-Farber to present more than 40 research studies at 2020 ASH Annual Meeting

Dana-Farber Cancer Institute researchers will present more than 40 research studies at the virtual 62nd American Society of Hematology (ASH) Annual Meeting on December 5-8, including two studies that were selected for inclusion in the official...
1-Dec-2020 2:45 PM EST Add to Favorites

Medicaid expansion linked to lower mortality rates for three major types of cancer

In states that have expanded Medicaid availability as part of the Affordable Care Act (ACA), mortality rates for three major forms of cancer are significantly lower than in states that have not expanded their Medicaid, a new study by researchers at...
4-Nov-2020 2:05 PM EST Add to Favorites

Newswise: PasiJanne_DFCI.jpg

Targeted inhibitor of mutated KRAS gene shows promise in early trial for lung, bowel, and other solid tumors

A novel agent that targets a mutated form of the KRAS gene – the most commonly altered oncogene in human cancers and one long considered “undruggable” – shrank tumors in most patients in a clinical trial with manageable side effects,...
24-Oct-2020 4:30 AM EDT Add to Favorites

Study offers global review of impact of COVID-19 on cancer treatment and research

The report, by researchers at Dana-Farber Cancer Institute and other institutions, suggests that while COVID-19 has complicated the treatment of cancer patients, it has also spurred creative solutions to challenges in clinical care, and research...
6-Oct-2020 12:45 PM EDT Add to Favorites

Immunotherapy Combination Improves Outcomes in Advanced Kidney Cancer

An immunotherapy agent combined with a tyrosine kinase inhibitor drug significantly improved progression-free survival and reduced the risk of death compared to a single agent treatment in advanced kidney cancer patients, according to first results...
19-Sep-2020 12:05 AM EDT Add to Favorites

Daily coffee consumption associated with improved survival in patients with metastatic colorectal cancer

In a large group of patients with metastatic colorectal cancer, consumption of a few cups of coffee a day was associated with longer survival and a lower risk of the cancer worsening, researchers at Dana-Farber Cancer Institute and other...
16-Sep-2020 1:05 PM EDT Add to Favorites

Dana-Farber to offer first CAR T-cell therapy for mantle cell lymphoma following FDA approval

Today’s Food and Drug Administration (FDA) approval of the first CAR T-cell therapy for mantle cell lymphoma (MCL) represents a key advance for patients with relapsed or treatment-resistant forms of the disease, say Dana-Farber Cancer Institute...
24-Jul-2020 3:10 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: Dr.JeffreyMeyerhardtFINAL.jpg

Colorectal Cancer: Five Things You Need To Know

With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST

Newswise: AnnPartridge.jpg

Leading Breast Cancer Expert Available to Comment on Young Women with Breast Cancer

11-Nov-2013 5:00 PM EST

Newswise: PF_SOG_7837.jpg

National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support

17-Sep-2013 3:00 PM EDT

Newswise: Dr.Haddadphoto.jpg

Vaccinating Children Against HPV?

The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT

Newswise: Andrea_Patenaude.jpg

Prophylactic Double Mastectomy: Angelina Makes a Private Choice a Public Issue

24-May-2013 3:00 PM EDT

Newswise: Carlos_Rodriguez-Galindo_SOG_6619_09.jpg

News Tip: New Research on Teenage Girls and Melanoma Makes This the Season for Tanning Stories

Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT

Healthy Holiday Helpings: Experts Offer Tips to Fight Cancer with Your Fork This Holiday Season

The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
23-Oct-2009 1:00 PM EDT

See All Experts

Our YouTube Videos

About

The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.

Experts

Contacts

Ellen Berlin
Media Relations Director

ellen_berlin@dfci.harvard.edu

617-632-5357

Robert Levy
Science Writer

robert_levy@dfci.harvard.edu

617-632-4090

Molly McHale
Associate Director for Communications

molly_mchale@dfci.harvard.edu

617-632-5675

Richard Saltus
Senior Science Writer

richard_saltus@dfci.harvard.edu

617-632-5643

Donna Walthall
Marketing Director

donna_walthall@dfci.harvard.edu

617-632-5856

Marlena Baldacci
National Media Relations Manager

marlena_Baldacci@dfci.harvard.edu

857-215-1204

Peter Cohenno
Senior Media Relations Specialist

Peter_Cohenno@dfci.harvard.edu

Claire Monaghan
Senior Media Relations Specialist
hematology

Claire_Monaghan@dfci.harvard.edu

617-632-5653

John Noble
Senior Media Relations Specialist
Health Care

johnw_noble@dfci.harvard.edu

617-632-5784

Quincey Spagnoletti
Media Relations Specialist

quinceym_spagnoletti@dfci.harvard.edu

315-720-2715

Victoria Warren
Media Relations Manager

Victoria_Warren@dfci.harvard.edu

617-582-9323

Twitter

close
2.70119